0000000001197946

AUTHOR

Eugenia Hopps

showing 62 related works from this author

Pathophysiology of polymorphonuclear leukocyte in arterial hypertension

2009

This review shows how polymorphonuclear leukocytes (PMNs) play a pivotal role in the development of the organ injury that is associated with arterial hypertension. Elevated white blood cell count and higher levels of PMNs activation are risk factors for arterial hypertension and cardiovascular disease. Spontaneously activated PMNs release proinflammatory factors and reactive oxygen species, which have negative effects on vascular tone and on their adhesion to the endothelium. The oxidative stress in hypertensive PMNs is revealed by increased NADPH-oxidase production and lipid peroxidation and by decreased cytosolic and mitochondrial superoxide dismutase concentrations. The overexpression of…

medicine.medical_specialtyEndotheliumNeutrophilsPhysiologyPolymorphonuclear leukocyte Hypertension oxidative stress adhesion moleculesmedicine.disease_causeProinflammatory cytokineSuperoxide dismutaseLipid peroxidationLeukocyte Countchemistry.chemical_compoundPhysiology (medical)Internal medicinemedicineHumansLeukocyte Rollingchemistry.chemical_classificationReactive oxygen speciesNADPH oxidasebiologySuperoxide Dismutasebusiness.industryCell adhesion moleculeNADPH OxidasesHematologymedicine.anatomical_structureEndocrinologychemistryCD18 AntigensHypertensionImmunologybiology.proteinLipid PeroxidationCardiology and Cardiovascular MedicinebusinessOxidative stressClinical Hemorheology and Microcirculation
researchProduct

Plasma Viscosity and NLR in Young Subjects with Myocardial Infarction: Evaluation at the Initial Stage and at 3 and 12 Months

2018

In the “Sicilian study on juvenile myocardial infarction,” we had evaluated plasma viscosity (PV) and neutrophil/lymphocyte ratio (NLR) in patients with acute myocardial infarction (AMI) at the age of ⩽45 years. Now, we examined the relationship between these 2 parameters in 120 subjects (109 men and 11 women) aged ⩽45 years with recent AMI. The patients were classified according to the number of cardiovascular risk factors, the electrocardiographic criteria (ST-segment elevation myocardial infarction [STEMI] or non-ST-segment elevation myocardial infarction [NSTEMI]), and the extent of coronary stenosis, evaluated with coronary angiography. On fasting venous blood, we measured PV at the sh…

lcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtySettore MED/09 - Medicina Internabusiness.industryLymphocytefungimedicine.diseaseneutrophil lymphocyte ratiomedicine.anatomical_structurelcsh:RC666-701Internal medicinecardiovascular systemCardiologyMedicineplasma viscosityIn patientcardiovascular diseasesMyocardial infarctionjuvenile myocardial infarctionStage (cooking)Cardiology and Cardiovascular MedicinebusinessPlasma viscosityOriginal ResearchClinical Medicine Insights: Cardiology
researchProduct

Gelatinases and their tissue inhibitors in metabolic syndrome

2014

medicine.medical_specialtyGelatinasesEndocrinologySettore MED/09 - Medicina Internabusiness.industryInternal medicinemedicineMetabolic syndromeCardiology and Cardiovascular Medicinebusinessmedicine.diseaseMetalloproteinase Diabetes mellitus
researchProduct

Protein oxidation in a group of subjects with metabolic syndrome.

2013

Abstract Aims To examine the protein oxidation, marker of the oxidative stress, in metabolic syndrome (MS). Methods We enrolled 106 subjects (45 women and 61 men) with MS of which 43 (14 women and 27 men) were with diabetes mellitus and 63 (31 women and 32 men) were without diabetes mellitus, and 54 subjects (19 women and 35 men) as control group. The protein oxidation, expressed as carbonyl groups, was measured by an enzyme-like immunosorbent assay (ELISA) kit (BioCell PC test kit, Enzo Life Sciences AG, Switzerland). Results In the whole group of MS subjects, in comparison with control group, a significant increase in carbonyl groups was present. The same datum was also evident between co…

Blood GlucoseMalemedicine.medical_specialtyWaistEndocrinology Diabetes and MetabolismIndiaBlood PressureProtein oxidationmedicine.disease_causeNitric OxideProtein CarbonylationInternal medicineDiabetes mellitusinsulin resistanceInternal MedicinemedicineHumansInflammationMetabolic Syndromeoxidative strebusiness.industryGeneral MedicineMiddle Agedmedicine.diseaseOxidative StressEndocrinologyBlood pressureDiabetes Mellitus Type 2FemaleMetabolic syndromeWaist CircumferencebusinessOxidation-ReductionOxidative stressBiomarkersDiabetesmetabolic syndrome
researchProduct

Lipid Peroxidation, Nitric Oxide Metabolites, and Their Ratio in a Group of Subjects with Metabolic Syndrome

2014

Our aim was to evaluate lipid peroxidation, expressed as thiobarbituric acid-reactive substances (TBARS), nitric oxide metabolites (nitrite + nitrate) expressed asNOx, and TBARS/NOxratio in a group of subjects with metabolic syndrome (MS). In this regard we enrolled 106 subjects with MS defined according to the IDF criteria, subsequently subdivided into diabetic (DMS) and nondiabetic (NDMS) and also into subjects with a low triglycerides/HDL-cholesterol (TG/HDL-C) index or with a high TG/HDL-C index. In the entire group and in the four subgroups of MS subjects we found an increase in TBARS andNOxlevels and a decrease in TBARS/NOxratio in comparison with normal controls. Regarding all these …

AdultMaleAgingmedicine.medical_specialtySettore MED/09 - Medicina InternaArticle SubjectInflammationNitric OxideThiobarbituric Acid Reactive SubstancesBiochemistryNitric oxideLipid peroxidationchemistry.chemical_compoundInsulin resistanceInternal medicinemedicineTBARSHumanslcsh:QH573-671NitriteNitritesTriglyceridesNOxMetabolic SyndromeNitrateslcsh:CytologyCell BiologyGeneral MedicineMiddle Agedmedicine.diseaseEndocrinologyBiochemistrychemistryLipid Peroxidation Nitric Oxide Metabolites Metabolic SyndromeFemaleLipid Peroxidationmedicine.symptomMetabolic syndromeLipoproteins HDLResearch ArticleOxidative Medicine and Cellular Longevity
researchProduct

Behaviour of carbonyl groups in several clinical conditions: Analysis of our survey

2019

Protein carbonylation is a marker of oxidative protein damage, that is likely involved in the pathogenesis of several diseases. The aim of this study was to evaluate the protein carbonyl (PC) groups in different clinical conditions. It included different groups of subjects: 81 trained subjects; 23 subjects with mild essential hypertension; 31 middle-aged subjects with metabolic syndrome (MS); 106 subjects with MS not selected for age (subdivided into two subgroups, with and without diabetes mellitus); 91 obese adults subdivided in two subgroups (BMI 30-35 Kg/m2 and BMI > 35 kg/m2); 48 subjects with obstructive sleep apnea syndrome (OSAS) subdivided in accordance with the apnea/hypopnea i…

AdultMalemedicine.medical_specialtyOxidative stress arterial hypertension metabolic syndrome juvenile myocardial infarction chronic kidney failurePhysiologymedicine.medical_treatment030204 cardiovascular system & hematologyEssential hypertension030218 nuclear medicine & medical imagingProtein Carbonylation03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesPhysiology (medical)Internal medicineDiabetes mellitusmedicineHumansDiseaseMyocardial infarctionDialysisbusiness.industryHematologymedicine.diseaseObstructive sleep apneaFemaleMetabolic syndromeCardiology and Cardiovascular MedicinebusinessOxidation-ReductionHypopneaBiomarkersKidney diseaseClinical Hemorheology and Microcirculation
researchProduct

Oxidative status in metabolic syndrome

2014

medicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinologybusiness.industryInternal medicineLipid peroxidation Total antioxidant statusMedicineOxidative phosphorylationMetabolic syndromeCardiology and Cardiovascular Medicinebusinessmedicine.diseaseAtherosclerosis
researchProduct

Nitric oxide metabolites and erythrocyte deformability in a group of subjects with obstructive sleep apnea syndrome

2014

Our aim was to evaluate nitric oxide metabolites (nitrite and nitrate), expressed as NOx, and erythrocyte deformability, expressed as elongation index, in a group of subjects with obstructive sleep apnea syndrome (OSAS). We enrolled 48 subjects (36 men and 12 women; mean age 50.3 ± 14.68 yrs) with OSAS diagnosed after a 1-night cardiorespiratory sleep study. OSAS severity was assessed evaluating the apnea/hypopnea index (AHI) and subjects were subdivided in two subgroups: Low (L = AHI 30). NOx was examined converting nitrate into nitrite with a nitrate reductase and then assessing nitrite with spectrophotometry after the addition of Griess reagent. The elongation index was obtained using th…

AdultMaleerythrocyte deformabilitymedicine.medical_specialtySettore MED/09 - Medicina InternaPhysiologyNOxNitric OxideNitric oxidechemistry.chemical_compoundstomatognathic systemGriess testPhysiology (medical)Internal medicinemedicineHumansErythrocyte deformabilitySleep studyNitriteNitritesAgedSleep Apnea ObstructiveNitratesbusiness.industryApneaOSASHematologyMiddle Agedmedicine.diseaserespiratory tract diseasesSurgeryObstructive sleep apneaEndocrinologychemistryblood rheology nitric oxide metabolism laser diffractometryFemalemedicine.symptomCardiology and Cardiovascular MedicinebusinessHypopnea
researchProduct

Lipid peroxidation and nitric oxide metabolites in a group of subjects with obstructive sleep apnea syndrome.

2015

It is known that in OSAS the plasma lipid peroxidation has an opposite behavior in comparison with nitric oxide metabolites. In the re-examination of our survey of OSAS subjects we calculated the ratio between thiobarbituric acid reactive substances (TBARS) and nitric oxide metabolites (NOx) in relation to OSAS severity. The study has regarded 48 OSAS subjects subdivided in two subgroups according to the apnea/hypopnea index - AHI- (Low = 21 subjects with AHI30 and High = 27 subjects with AHI30). From the obtained data it is evident that the TBARS/NOx ratio is significantly higher in the H subgroup compared to L subgroup as well as this ratio is reduced in L subgroup in comparison with the …

Malemedicine.medical_specialtyPhysiologyThiobarbituric acidobstructive sleep apnea syndrome030204 cardiovascular system & hematologyNitric OxideNitric oxideLipid peroxidation03 medical and health scienceschemistry.chemical_compound0302 clinical medicinestomatognathic systemnitric oxide metabolitePhysiology (medical)Internal medicineTBARSLipid peroxidation; nitric oxide metabolites; obstructive sleep apnea syndrome; Female; Humans; Lipid Peroxidation; Male; Middle Aged; Nitric Oxide; Sleep Apnea Obstructive; Physiology; Hematology; Cardiology and Cardiovascular Medicine; Physiology (medical)MedicineHumansNOxSleep Apnea Obstructivebusiness.industryApneaHematologyMiddle Agedmedicine.diseasenervous system diseasesrespiratory tract diseasesObstructive sleep apneaEndocrinology030228 respiratory systemchemistryFemaleLipid Peroxidationmedicine.symptomCardiology and Cardiovascular MedicinebusinessHypopneaHumanClinical hemorheology and microcirculation
researchProduct

Erythrocyte deformability, plasma lipid peroxidation and plasma protein oxidation in a group of OSAS subjects

2016

Considering that obstructive sleep apnea syndrome (OSAS) is usually associated with endothelial dysfunction, atherosclerosis and cardiovascular disorders, our aim was to examine the erythrocyte deformability and the oxidative status in a group of OSAS subjects. We consecutively enrolled 48 subjects with OSAS defined after a 1-night cardiorespiratory sleep study, subsequently subdivided according to the apnea/hypopnea index (AHI) value in two subgroups: Low (L = 21 subjects with AHI30) and High (H = 27 subjects with AHI30). We evaluated the erythrocyte deformability, expressed as elongation index (EI) and the parameters of the oxidative status, such as lipid peroxidation (expressed as thioba…

Malemedicine.medical_specialtyPhysiologyLipid peroxidation030204 cardiovascular system & hematologymedicine.disease_causeProtein oxidationBioinformaticsLipid peroxidation03 medical and health scienceschemistry.chemical_compound0302 clinical medicineBlood Proteinstomatognathic systemErythrocyte DeformabilityPhysiology (medical)Internal medicineErythrocyte deformability; Lipid peroxidation; OSAS; Protein oxidation; Blood Proteins; Erythrocyte Deformability; Female; Humans; Lipid Peroxidation; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Sleep Apnea Obstructive; Physiology; Hematology; Cardiology and Cardiovascular Medicine; Physiology (medical)medicineTBARSHumansErythrocyte deformabilitySleep Apnea Obstructivebusiness.industryErythrocyte fragilityOSASOxidative StreBlood ProteinsHematologyMiddle Agedmedicine.diseaseBlood proteinsnervous system diseasesrespiratory tract diseasesOxidative StressEndocrinology030228 respiratory systemchemistryFemaleCardiology and Cardiovascular MedicinebusinessProtein oxidationOxidation-ReductionHypopneaOxidative stressHumanClinical Hemorheology and Microcirculation
researchProduct

Short-Term Prognosis of Juvenile Myocardial Infarction

2016

In our early research regarding the hemorheological pattern in patients with acute myocardial infarction (AMI) with a mean age of 61.45 + 10.99 years, we showed that the major hemorheological parameters were almost normalized 2 weeks after the acute event. In the last decade, we focused on hemorheological parameters in juvenile myocardial infarction (JMI), defined as AMI in patients aged 45 years, in the ‘‘Sicilian study on juvenile myocardial infarction’’. Juvenile myocardial infarction is responsible for 2% to 10% of all cases with AMI in different surveys. Juvenile myocardial infarction presents a typical pattern of risk factors and shows clinical, angiographic, and prognostic characteri…

AdultMalemedicine.medical_specialtyTime FactorsIschemic heart diseaseBlood viscosity030204 cardiovascular system & hematologyBlood rheology030218 nuclear medicine & medical imagingAnginaCoronary artery diseasePlasma03 medical and health sciences0302 clinical medicineRisk FactorsDiabetes mellitusInternal medicinemedicineHumansMyocardial infarctionAge of OnsetRisk factorNon-ST Elevated Myocardial InfarctionBlood rheology; Myocardial infarction; Ischemic heart diseaseMedicine (all); Cardiology and Cardiovascular Medicinebusiness.industryMedicine (all)HemodynamicsBlood ViscosityPrognosismedicine.diseaseMyocardial infarctionHeart failureCoronary vesselDisease ProgressionCardiologyST Elevation Myocardial InfarctionFemaleCardiology and Cardiovascular MedicinebusinessAngiology
researchProduct

Interrelationships between oxidative stress and MMP-9 in subjects with severe obstructive sleep apnea syndrome

2016

Obstructive sleep apnea syndrome (OSAS) is significantly and independently associated with an increased risk of cardiovascular diseases, cerebrovascular events and all-cause mortality and some studies have demonstrated that the incidence of cardiovascular events is related to its severity. Our aim was to examine the oxidative status and the matrix metalloproteases (MMP) profile in a group of subjects with OSAS. We enrolled 48 subjects with OSAS, defined after a 1-night cardiorespiratory sleep study, which were subsequently subdivided in two subgroups according to the severity of OSAS: mild-moderate OSAS = “Low”, severe OSAS = “High”. We measured the parameters of oxidative stress, such as l…

medicine.medical_specialtybusiness.industryCardiorespiratory fitnessmedicine.disease_causemedicine.diseaseProtein oxidationLipid peroxidationObstructive sleep apneachemistry.chemical_compoundEndocrinologychemistryInternal medicinemedicineTBARSSleep studyEndothelial dysfunctionbusinessOxidative stress4.2 Sleep and Control of Breathing
researchProduct

Oxidative status in nondiabetic middle-aged subjects with metabolic syndrome: preliminary data.

2013

AdultMaleEndocrinology Diabetes and MetabolismMedicine (miscellaneous)PhysiologyEnzyme-Linked Immunosorbent AssayOxidative phosphorylationNitric OxideAntioxidantsProtein CarbonylationText miningMedicineHumansTriglyceridesMetabolic SyndromeNutrition and Dieteticsbusiness.industryCholesterol HDLMiddle Agedmedicine.diseaseOxidative StressLinear ModelsFemaleLipid PeroxidationMetabolic syndromeCardiology and Cardiovascular MedicinebusinessLipid peroxidation total antioxidant status insulin resistanceNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct

Effects of exercise on inflammation markers in type 2 diabetic subjects

2011

Endothelial dysfunction and plasma markers of inflammation are significantly increased in type 2 diabetics. Several proinflammatory cytokines, acute-phase proteins, and cell adhesion molecules, such as C-reactive protein (CRP), interleukines (IL), and tumor necrosis factor alpha (TNF-α), seem to play a role in the low-grade systemic inflammation observed in these subjects. Lifestyle changes are necessary to prevent atherosclerosis and cardiovascular events. Physical exercise is known to reduce markers of inflammation by decreasing adipocytokine production and cytokine release from skeletal muscles, endothelial cells, and immune system and also improving antioxidant status. In type 2 diabeti…

medicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentInflammationPhysical exerciseSystemic inflammationProinflammatory cytokineEndocrinologyAdipokinesInternal medicinediabetesexerciseinflammation markersInternal MedicinemedicineHumansAerobic exerciseExerciseInflammationAdiponectinbusiness.industryGeneral MedicineExercise TherapyCytokineEndocrinologyDiabetes Mellitus Type 2CytokinesResistinmedicine.symptombusinessBiomarkersActa Diabetologica
researchProduct

Gelatinases and their tissue inhibitors in a group of subjects with obstructive sleep apnea syndrome.

2016

Obstructive sleep apnea syndrome (OSAS) is associated with an elevated risk of cardiovascular events and stroke. Matrix metalloproteinases (MMPs) are endopeptidases involved in extracellular matrix degradation and then in the development and progression of cardiovascular diseases. Our aim was to evaluate plasma levels of gelatinases (MMP-2 and MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in a group of subjects with OSAS. We enrolled 48 subjects (36 men and 12 women; mean age 49.7 ± 14.68 yrs) with OSAS diagnosed with a 1-night cardiorespiratory study and then we subdivided these subjects into two subgroups according to the apnea/hypopnea index (AHI): Low (L = 21 subjects with AHI …

Malemedicine.medical_specialtyGelatinasesSettore MED/09 - Medicina InternaPhysiologyMMP-2; MMP-9; obstructive sleep apnea; TIMP-1; TIMP-2; Disease Progression; Female; Gelatinases; Humans; Male; Middle Aged; Sleep Apnea Obstructive; Tissue Inhibitor of Metalloproteinase-1; Physiology; Hematology; Cardiology and Cardiovascular Medicine; Physiology (medical)030204 cardiovascular system & hematologyMatrix metalloproteinaseGastroenterologyTIMP-203 medical and health sciencesTIMP-10302 clinical medicinePhysiology (medical)Internal medicinemedicineHumansStrokeobstructive sleep apneaOxygen saturation (medicine)Sleep Apnea ObstructiveTissue Inhibitor of Metalloproteinase-1MMP-2business.industryApneaCardiorespiratory fitnessHematologyMiddle Agedmedicine.diseasenervous system diseasesrespiratory tract diseasesObstructive sleep apneaEndocrinology030228 respiratory systemGelatinaseGelatinasesDisease ProgressionFemalemedicine.symptomMMP-9Settore MED/36 - Diagnostica Per Immagini E RadioterapiaCardiology and Cardiovascular MedicinebusinessHypopneaHumanClinical hemorheology and microcirculation
researchProduct

Protein oxidation in chronic kidney disease.

2013

An imbalance between oxidative processes and antioxidant systems has been widely demonstrated in chronic kidney diseases (CKD). In this study we enrolled 26 healthy subjects, 27 patients with CKD on conservative treatment (CT-CKD) with various degrees of renal failure, and 31 CKD subjects in haemodialysis treatment (HD-CKD), evaluated before and after a standard haemodialysis session. In each group we measured protein carbonyl groups (PC) as an index of protein oxidation, lipid peroxidation (TBARS) and two plasma markers of leukocyte activation, elastase and myeloperoxidase (MPO). In CT-CKD subjects the PC level was significantly higher than in normal controls, and it was negatively correla…

MaleHEMODIALYSISmedicine.medical_specialtySettore MED/09 - Medicina InternaPhysiologyBIOMARKERSRenal functionurologic and male genital diseasesProtein oxidationThiobarbituric Acid Reactive SubstancesLipid peroxidationDiabetes Complicationschemistry.chemical_compoundCARBONYL STRESSMARKERSINFLAMMATIONGlycationRenal DialysisPhysiology (medical)Internal medicinemedicineTBARSHumansRenal Insufficiency ChronicPeroxidasebiologyPancreatic Elastasebusiness.industryNITRIC-OXIDE METABOLITESElastaseHematologyMiddle Agedmedicine.diseasefemale genital diseases and pregnancy complicationsOxidative StressEndocrinologychemistryMyeloperoxidaseNITRIC-OXIDE METABOLITES; CHRONIC-RENAL-FAILURE; CARBONYL STRESS; HEMODIALYSIS; BIOMARKERS; MARKERS; INFLAMMATIONImmunologybiology.proteinFemaleCHRONIC-RENAL-FAILURELipid PeroxidationCardiology and Cardiovascular MedicinebusinessOxidation-ReductionKidney diseaseClinical hemorheology and microcirculation
researchProduct

Nitric oxide metabolites and oxidative stress in mild essential hypertension

2010

Many papers have showed non univocal data about oxidative stress status and nitric oxide metabolites in essential hypertension. Considering this preamble we examined the total antioxidant status (TAS), the lipid peroxidation (LP), expressed as thiobarbituric acid-reactive substances (TBARS), the stable end products of nitric oxide (NOx) and LP/NOx ratio in 25 subjects with untreated mild essential hypertension. The obtained data show a significant increase in TBARS (p < 0.001) and NOx (p < 0.001) in hypertensives and no variation in TAS and in TBARS/NOx ratio. None of these parameters was statistically related to the metabolic parameters or to the blood pressure values. The high level of li…

AdultMalemedicine.medical_specialtyAntioxidantPhysiologymedicine.medical_treatmentBlood PressureEssential hypertensionmedicine.disease_causeThiobarbituric Acid Reactive SubstancesAntioxidantsNitric oxideEssential hypertension.Lipid peroxidationchemistry.chemical_compoundPhysiology (medical)Internal medicinemedicineTBARSHumansNOxOxidate streNitric oxideHematologyMiddle Agedmedicine.diseaseOxidative StressBlood pressureEndocrinologychemistryBiochemistryHypertensionFemaleLipid PeroxidationCardiology and Cardiovascular MedicineOxidative stressClinical Hemorheology and Microcirculation
researchProduct

Behaviour of the neutrophil to lymphocyte ratio in young subjects with acute myocardial infarction

2016

In the last years the neutrophil to lymphocyte ratio (NLR) has been examined in cardiovascular disorders and in particular in coronary artery disease and acute myocardial infarction (AMI). Now we examined this parameter in subjects with juvenile myocardial infarction at the initial stage and after 3 and 12 months. We enrolled 123 young subjects (112 men and 11 women, mean age 39.4 ± 5.8 yrs) with AMI. The time interval between the AMI onset and the investigation was 13 ± 7 days. The mean value of NLR observed in young AMI subjects was significantly increased compared to normal controls (N = 1.817 ± 0.711; young AMI subjects = 2.376 ± 0.873, p <  0.0001). NLR does not discriminate STEMI (2.4…

MaleNeutrophilsPhysiologyLymphocyteMyocardial InfarctionCoronary Artery Disease030204 cardiovascular system & hematologyCoronary AngiographyCoronary artery diseaseLeukocyte Count0302 clinical medicineRetrospective StudieRisk FactorsMedicineLymphocytes030212 general & internal medicineMyocardial infarctionStage (cooking)HematologyNeutrophilSmokingJuvenile myocardial infarction; leukocyte count; neutrophil/lymphocyte ratio; Adult; Biomarkers; Coronary Angiography; Coronary Artery Disease; Female; Humans; Inflammation; Leukocyte Count; Lymphocyte Count; Lymphocytes; Male; Middle Aged; Myocardial Infarction; Neutrophils; Prognosis; Retrospective Studies; Risk Factors; ST Elevation Myocardial Infarction; Smoking; Physiology; Hematology; Cardiology and Cardiovascular Medicine; Physiology (medical)HematologyMiddle AgedPrognosismedicine.anatomical_structureAbsolute neutrophil countCardiologyLymphocyteFemaleCardiology and Cardiovascular MedicineHumanAdultmedicine.medical_specialtyPrognosi03 medical and health sciencesPhysiology (medical)Internal medicineHumansLymphocyte Countcardiovascular diseasesNeutrophil to lymphocyte ratioRetrospective StudiesInflammationbusiness.industryRisk FactorRetrospective cohort studyBiomarkermedicine.diseaseJuvenile myocardial infarctionneutrophil/lymphocyte ratioST Elevation Myocardial InfarctionbusinessBiomarkersClinical Hemorheology and Microcirculation
researchProduct

Hemorheological abnormalities in human arterial hypertension

2014

Blood rheology is impaired in hypertensive patients. The alteration involves blood and plasma viscosity, and the erythrocyte behaviour is often abnormal. The hemorheological pattern appears to be related to some pathophysiological mechanisms of hypertension and to organ damage, in particular left ventricular hypertrophy and myocardial ischemia. Abnormalities have been observed in erythrocyte membrane fluidity, explored by fluorescence spectroscopy and electron spin resonance. This may be relevant for red cell flow in microvessels and oxygen delivery to tissues. Although blood viscosity is not a direct target of antihypertensive therapy, the rheological properties of blood play a role in the…

erythrocyte deformabilitymedicine.medical_specialtySettore MED/09 - Medicina InternaRed Cellbusiness.industryerythrocyte membraneBlood viscosityessential hypertensionessential hypertension blood viscosity erythrocyte deformabilityCondensed Matter PhysicsEssential hypertensionmedicine.diseaseLeft ventricular hypertrophyPathophysiologyErythrocyte membraneInternal medicinePathophysiology of hypertensionblood viscositymedicineCardiologyErythrocyte deformabilityGeneral Materials SciencebusinessKorea-Australia Rheology Journal
researchProduct

Evaluation of nitric oxide metabolites in a group of subjects with metabolic syndrome.

2012

Abstract Aim To evaluate the concentration of metabolites (NO2−, NO3−) of nitric oxide (NO) in metabolic syndrome (MS). Materials and methods We enrolled 106 subjects (45 women and 61 men) with MS of which 43 (14 women and 27 men) with diabetes mellitus and 63 (31 women and 32 men) without diabetes mellitus, and 54 subjects (19 women and 35 men) as control group. The nitric oxide metabolites (nitrite + nitrate = NOx) were evaluated employing the Griess reagent. Results In the whole group of MS subjects was evident, in comparison with control group, a significant increase in NOx. The same finding was also present between control group and diabetic subjects with MS and between control group a…

Nitric oxide metaboliteinorganic chemicalsMalemedicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinology Diabetes and Metabolismmedicine.disease_causeNitric OxideNitric oxidechemistry.chemical_compoundGriess testInternal medicineDiabetes mellitusInternal MedicinemedicineHumansNitritesInflammationMetabolic SyndromeNitratesbusiness.industryGeneral MedicineFastingAnthropometryMiddle AgedNitric oxide metabolismmedicine.diseaseOxidative StressBlood pressureEndocrinologychemistryDiabetes Mellitus Type 2Oxidative streFemaleMetabolic syndromebusinessOxidative stressBiomarkersDiabetesmetabolic syndrome
researchProduct

Protein carbonyl groups in trained subjects before and after a cardiopulmonary test

2013

Physical exercise influences the body's oxidative status. The modifications can involve lipids, proteins and nucleic acids, and different effects seem to be induced by regular and acute exercise respectively. We examined protein oxidation, expressed as concentration of protein carbonyl groups (PC), in trained subjects before (time 0), 10 min (time 1) and 24 hours (time 2) after a cardiopulmonary test performed on a cycloergometer. We enrolled 38 trained subjects (26 men and 12 women), subdivided in two groups (A1 and B1) of 19 subjects each, according to the median value of VO2max, and in two groups (A2 and B2) of 19 subjects each, according to the median value of PC at baseline. PC concent…

AdultMalemedicine.medical_specialtyPathologyPhysiologyEnzyme-Linked Immunosorbent AssayPhysical exerciseProtein oxidationProtein Carbonylationoxidative stress ergometry sport physiologyBasal (phylogenetics)Physiology (medical)Internal medicinemedicineHumansAerobic exerciseExerciseTrained subjectsbusiness.industryHematologyEndocrinologyExercise TestFemaleCardiology and Cardiovascular MedicineProtein carbonylbusinessCardiopulmonary testClinical Hemorheology and Microcirculation
researchProduct

Fluidity and cytosolic Ca2+ concentration of circulating polymorphonuclear leukocytes at baseline in some chronic and acute clinical conditions: revi…

2016

Abstract. Objective: In this mini-review we describe the behavior of polymorphonuclear leukocyte (PMN) membrane fluidity and of PMN cytosolic Ca2+ concentration in some chronic and acute clinical conditions. Methods: PMN membrane fluidity was evaluated employing the fluorescent probe Fura-2AM, and PMN cytosolic Ca2+ concentration was evaluated using the fluorescent probe TMA-DPH. Results: From the determination of these two parameters investigated on resting PMNs, an almost constant increase in PMN cytosolic Ca2+ concentration in chronic clinical conditions, such as vascular atherosclerotic disease with and without diabetes mellitus, essential hypertension, chronic kidney disease, and diabe…

acute ischemic strokemedicine.medical_specialtyClinical BiochemistryCell calciumEssential hypertensionBiochemistryInorganic ChemistryCell calcium; membrane fluidity; fluorescence spectroscopy; polymorphonuclear leukocyte; vascular atherosclerotic disease; diabetes mellitus; chronic kidney disease; essential hypertension; myocardial infarction; acute ischemic strokevascular atherosclerotic diseaseDiabetes mellitusInternal medicineCa2 concentrationmedicineMembrane fluidityMyocardial infarctionAcute ischemic strokePolymorphonuclear leukocytediabetes mellitubusiness.industrymembrane fluiditypolymorphonuclear leukocyteessential hypertensionfluorescence spectroscopymedicine.diseaseCytosolmyocardial infarctionCardiologybusinesschronic kidney disease
researchProduct

Behavior of the total antioxidant status in a group of subjects with metabolic syndrome.

2014

AIM: Our purpose was to examine the total antioxidant status (TAS) in subjects with metabolic syndrome (MS) subdivided according to the presence or not of diabetes mellitus. METHODS: We enrolled 106 subjects (45 women, 61 men) with MS subsequently subdivided in diabetics (14 women, 29 men) and nondiabetics (31 women, 29 men). TAS was obtained using an Assay kit which relies on the ability of plasma antioxidant substances to inhibit the oxidation of 2,2'-azino-bis(3-ethylbenzthiazoline sulfonic acid) to the radical ABTS+. RESULTS: In the group of MS subjects a significant decrease in TAS (p<0.05) in comparison with normal controls was evident. This difference was present between normal subje…

AdultBlood GlucoseMalemedicine.medical_specialtyanimal structuresAntioxidantSettore MED/09 - Medicina InternaBilirubinEndocrinology Diabetes and Metabolismmedicine.medical_treatmentBlood PressureAntioxidantschemistry.chemical_compoundInternal medicineDiabetes mellitusInternal MedicinemedicineHumansAgedMetabolic SyndromeABTSbusiness.industryBilirubinGeneral MedicineMiddle Agedmedicine.diseasePathophysiologyTOTAL ANTIOXIDANT STATUS METABOLIC SYNDROMEUric AcidAntioxidant capacityOxidative StressEndocrinologychemistryDiabetes Mellitus Type 2ItalyLinear ModelsUric acidFemaleMetabolic syndromebusiness
researchProduct

Matrix metalloproteinases in metabolic syndrome.

2011

Metabolic syndrome is commonly accompanied by an elevated cardiovascular risk with high morbidity and mortality. The alterations of the arterial vasculature begin with endothelial dysfunction and lead to micro- and macrovascular complications. The remodeling of the endothelial basal membrane, that promotes erosion and thrombosis, has a multifactorial pathogenesis that includes leukocyte activation, increased oxidative stress and also an altered matrix metalloproteinases (MMPs) expression. MMPs are endopeptidases which degrade extracellular matrix proteins, such as collagen, gelatins, fibronectin and laminin. They can be secreted by several cells within the vascular wall, but macrophages are…

medicine.medical_specialtySettore MED/09 - Medicina InternaMatrix metalloproteinaseGlobal HealthPathogenesisExtracellular matrixRisk FactorsDiabetes mellitusInternal medicineInternal MedicinemedicineHumansEndothelial dysfunctionMetabolic Syndromebiologybusiness.industryMETABOLIC SYNDROME MATRIX METALLOPROTEASES CARDIOVASCULAR RISKmedicine.diseaseMatrix MetalloproteinasesSurvival RateFibronectinOxidative StressEndocrinologyCardiovascular Diseasesbiology.proteinMorbidityMetabolic syndromebusinessDyslipidemia
researchProduct

Red blood cell deformability in multiple myeloma1.

2018

The aim of this study was the evaluation of the erythrocyte deformability in multiple myeloma (MM). We enrolled 29 MM patients and we evaluated, on fasting venous blood, the erythrocyte deformability, expressed as elongation index, and examined using the diffractometric method. By comparing normal controls and MM patients, a significant decrease in erythrocyte deformability, especially at low shear stresses, was found. In this research paper we evaluated all the hypothesis for a possible explanation of the behaviour of red blood cell deformability in MM, even considering how the alteration of erythrocyte deformability worsens the microcirculatory flow in these patients in association with t…

Malemedicine.medical_specialtyPhysiology030204 cardiovascular system & hematologyMicrocirculation03 medical and health sciences0302 clinical medicinePhysiology (medical)Internal medicineErythrocyte DeformabilitymedicineErythrocyte deformabilityHumansPlasma viscosityMultiple myelomaAgedHematologyChemistryMicrocirculationHematologyVenous bloodmedicine.diseaseMicrocirculatory flowRed blood cellmedicine.anatomical_structureEndocrinology030220 oncology & carcinogenesisFemaleCardiology and Cardiovascular MedicineMultiple MyelomaClinical hemorheology and microcirculation
researchProduct

A novel component of the metabolic syndrome: The oxidative stress

2009

The metabolic syndrome (MS) represents a cluster of cardiovascular (CV) risk factors associated to CV disease and type 2 diabetes. It is still under debate whether MS is a mere aggregation of risk factors or it represents a clinical entity with visceral obesity as underlying pathophysiological trigger. The publication of several diagnostic criteria of MS by scientific associations or experts panels reflects this uncertainty in understanding the real nature of MS. Besides the metabolic disturbances of MS, as visceral obesity, hypertriglyceridemia, low HDL cholesterol, hypertension and hyperglycemia, novel mechanisms of arterial damage have been identified. This paper reviews the evidence sho…

medicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismMedicine (miscellaneous)Blood lipidsType 2 diabetesDiseaseBiologyBioinformaticsmedicine.disease_causeRisk FactorsInternal medicineDiabetes mellitusmedicineAnimalsHumansDyslipidemiasInflammationMetabolic SyndromeNutrition and DieteticsHypertriglyceridemiaCardiovascular riskmedicine.diseaseObesityOxidative StressEndocrinologyDiabetes Mellitus Type 2Cardiovascular DiseasesObesity AbdominalHypertensionMetabolic syndromeCardiology and Cardiovascular MedicineOxidative stressNutrition, Metabolism and Cardiovascular Diseases
researchProduct

Analysis of the Blood Viscosity Behavior in the Sicilian Study on Juvenile Myocardial Infarction

2018

Considering the role of hemorheology in coronary circulation, we studied blood viscosity in patients with juvenile myocardial infarction. We examined whole blood viscosity at high shear rate using the cone-on-plate viscosimeter Wells-Brookfield ½ LVT and at low shear rate employing a viscometer Contraves LS30 in 120 patients (aged &lt;46 years) with myocardial infarction, at the initial stage and subsequently 3 and 12 months after. At the initial stage, patients had an increased whole blood viscosity in comparison to normal controls. This hemorheological profile was not influenced by the cardiovascular risk factors, nor by the extent of coronary lesions, even if some differences were evide…

AdultMalemedicine.medical_specialtyAcute coronary syndromeBlood viscosityInfarction030204 cardiovascular system & hematologyFollow-Up Studie03 medical and health sciencesCoronary circulation0302 clinical medicineInternal medicinemedicineHumanscardiovascular diseases030212 general & internal medicineMyocardial infarctionAcute Coronary SyndromeNeutrophil to lymphocyte ratioblood rheologybusiness.industryOriginal ArticlesHematologyGeneral MedicineMiddle AgedBlood Viscositymedicine.diseasemedicine.anatomical_structureItalyHeart failureCardiologyST Elevation Myocardial InfarctionFemaleHemorheologyjuvenile myocardial infarctionbusinessFollow-Up StudiesHumanClinical and Applied Thrombosis/Hemostasis
researchProduct

Pulmonary embolism in an emergency care unit of Southern Italy: Evaluation of predictive factors from clinical history and physical exam

2016

An early diagnosis of pulmonary embolism (PE) improves outcome. Therefore, PE should be diagnosed in Emergency Care Units (ECU) at admission. Clinical algorithms support the clinician in this task, although performance is biased by differences in risk factors prevalent in different populations. The clinical conditions predictive of PE were evaluated in subjects from Southern Italy accessing ECU for dyspnea/chest pain. Retrospective clinical data were obtained by electronic retrieving from a hospital database. Data from 8177 patients (age 18-90 years, 54 with PE) were collected from years 2007-2013. Previous history of PE, thrombosis and/or phlebitis, rheumatic diseases, respiratory failure,…

medicine.medical_specialtybiologyTroponin Tbusiness.industryC-reactive proteinChest painmedicine.diseaseThrombosisPulmonary embolismBlood pressureRespiratory failureEmergency medicinemedicinebiology.proteinmedicine.symptomIntensive care medicinebusinessGeneva score2.1 Acute Critical Care
researchProduct

Protein oxidation in metabolic syndrome

2013

Purpose: Oxidative stress plays a pivotal role in the pathogenesis of the metabolic syndrome and in the progression of its complications. Carbonylated proteins are a stable marker of severe oxidative stress because damage to the protein structure is irreversible and may cause an inhibition of their enzymatic activity or an increased susceptibility to proteolysis. There are few data regarding protein oxidation in metabolic syndrome, although elevated levels of carbonyl groups are often detected in subjects with obesity, diabetes mellitus, hypertension or dyslipidemia, well-known components of the metaboic syndrome. In particular, obesity, insulin resistance and diabetes mellitus are frequent…

medicine.medical_specialtySettore MED/09 - Medicina InternaProtein CarbonylationBiologyProtein oxidationmedicine.disease_causeProtein CarbonylationInsulin resistanceDiabetes mellitusInternal medicinemedicineAnimalsHumansMetabolic SyndromeInterleukin-6Tumor Necrosis Factor-alphaGeneral Medicinemedicine.diseaseOxidative Stressprotein oxidation metabolic syndromeEndocrinologyResistinMetabolic syndromeInsulin ResistanceDyslipidemiaOxidative stress
researchProduct

Haemorheological profile in congenital afibrinogenemia and in congenital dysfibrinogenemia: A clinical case report

2019

Although the inherited quantitative and qualitative disorders of fibrinogen are rare, in the course of time patients may develop complications including episodes of arterial and venous thrombosis. It can be useful to complete the laboratory assessment of these clinical conditions with the evaluation of the haemorheological profile. The data obtained from this study showed that congenital afibrinogenemia was characterized by a primary plasma hypoviscosity, whereas congenital dysfibrinogenemia by a primary plasma hyperviscosity. Both these haemorheological alterations may concur, with different mechanisms, to the pathogenesis of thrombotic vascular complications.

AdultMaleHypoviscosityPediatricsmedicine.medical_specialtyPhysiologyHyperviscosity030204 cardiovascular system & hematologyFibrinogen030218 nuclear medicine & medical imagingYoung Adult03 medical and health sciences0302 clinical medicinePhysiology (medical)medicineHumansAfibrinogenemiabusiness.industryCongenital dysfibrinogenemiaFibrinogenHematologyMiddle AgedAfibrinogenemiamedicine.diseaseCongenital afibrinogenemiaVenous thrombosisFemaleClinical caseCardiology and Cardiovascular MedicinebusinessHumanmedicine.drugClinical Hemorheology and Microcirculation
researchProduct

Protein oxidation in mild essential hypertension

2012

An intensified oxidative stress has been associated with aging and many disease, including essential hypertension (EH) [6, 11, 16]. In EH an increased level of reactive oxygen and nitrogen species (RONS) may impair the bioavailability of nitric oxide (NO), by inducing its accelerated transformation in peroxynitrite [4]. Beside this, many other pathophysiological processes in EH may be influenced by RONS, considering their harmful effects on the structural and functional properties of lipids, proteins and nucleic acids. Some points need to be further investigated, such as the relationship between oxidative stress and the degree of hypertension, and identification of the most useful marker of…

AdultMalemedicine.medical_specialtyAmbulatory blood pressurePhysiologyDiastoleEnzyme-Linked Immunosorbent Assaymedicine.disease_causeProtein oxidationEssential hypertensionLipid peroxidationProtein Carbonylationchemistry.chemical_compoundYoung Adultprotein oxidation essential hypertensionPhysiology (medical)Internal medicinemedicineHumansbusiness.industryHematologyBlood ProteinsMiddle Agedmedicine.diseaseBlood proteinsOxidative StressEndocrinologyBlood pressurechemistryCase-Control StudiesHypertensionFemaleCardiology and Cardiovascular MedicinebusinessOxidation-ReductionOxidative stress
researchProduct

Behaviour of the plasma concentration of gelatinases and their tissue inhibitors in subjects with venous leg ulcers.

2015

Venous leg ulcers are common in subjects with chronic venous insufficiency. The increased intraluminal pressure causes alteration of the skin microcirculation, leukocyte activation and release of proteolytic enzymes leading to ulceration. An impaired expression and activity of matrix metalloproteases (MMPs) and their tissue inhibitors (TIMPs) might influence extracellular matrix degradation and deposition in chronic venous ulcers with the failure of the healing process. Our aim was to evaluate plasma concentration of gelatinases (MMP-2 and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in subjects with venous leg ulcers before and after the compression therapy. We enrolled 36 subjects (12 …

Ulcer healingMalemedicine.medical_specialtyGelatinasesSettore MED/09 - Medicina InternaPhysiologyChronic venous insufficiencyMatrix metalloproteinaseGastroenterologyMicrocirculationVaricose UlcerTIMP-2TIMP-1Physiology (medical)Internal medicinemedicineHumansAgedTissue Inhibitor of Metalloproteinase-2Tissue Inhibitor of Metalloproteinase-1MMP-2business.industryMMP-2; MMP-9; TIMP-1; TIMP-2; Venous leg ulcersLeg UlcerProteolytic enzymesHematologyVenous bloodmedicine.diseaseMatrix MetalloproteinasesSurgeryVenous leg ulcersVenous InsufficiencyGelatinasesPlasma concentrationMatrix Metalloproteinase 2FemaleMMP-9Cardiology and Cardiovascular Medicinebusiness
researchProduct

Study of the Correlations among Some Parameters of the Oxidative Status, Gelatinases, and Their Inhibitors in a Group of Subjects with Metabolic Synd…

2014

Our aim was to examine some parameters of oxidative status, gelatinases, and their inhibitors and to evaluate their interrelationships in subjects with metabolic syndrome (MS). We enrolled 65 MS subjects, subdivided according to the presence or not of diabetes mellitus. We examined lipid peroxidation (expressed as thiobarbituric acid reacting substances, TBARS), protein oxidation (expressed as carbonyl groups), nitric oxide metabolites (NOx), total antioxidant status (TAS), MMP-2, MMP-9, TIMP-1, and TIMP-2. We found that MS subjects, diabetics and nondiabetics, showed an increase in TBARS, PC, and NOx. A significant decrease in TAS was observed only in nondiabetic MS subjects in comparison …

Malemedicine.medical_specialtyGelatinasesSettore MED/09 - Medicina InternaArticle SubjectThiobarbituric acidImmunologymedicine.disease_causeProtein oxidationNitric OxideThiobarbituric Acid Reactive SubstancesAntioxidantsLipid peroxidationchemistry.chemical_compoundOxidative Status Gelatinases Metabolic SyndromeInternal medicineDiabetes mellitusmedicineTBARSlcsh:PathologyHumansMetabolic SyndromeTissue Inhibitor of Metalloproteinase-2Tissue Inhibitor of Metalloproteinase-1business.industryCell BiologyMiddle Agedmedicine.diseaseEndocrinologychemistryBiochemistryMatrix Metalloproteinase 9GelatinasesMatrix Metalloproteinase 2FemaleLipid PeroxidationMetabolic syndromebusinessOxidative stresslcsh:RB1-214Research ArticleMediators of Inflammation
researchProduct

Matrix Metalloproteases in Arterial Hypertension and their Trend after Antihypertensive Treatment

2017

&lt;b&gt;&lt;i&gt;Background/Aims&lt;/i&gt;&lt;/b&gt;&lt;b&gt;&lt;i&gt;:&lt;/i&gt;&lt;/b&gt; Arterial hypertension is characterized by vascular remodelling, atherosclerosis and cardiovascular complications. Matrix metalloproteases (MPPs) are endopeptidases produced by all the cells present in the vascular wall and are involved in the regulation of the extracellular matrix protein turnover. MMPs contribute to blood vessel formation, remodelling, angiogenesis; whereas an altered expression or activity of MMPs or their tissue inhibitors (TIMPs) results correlated with the development and progression of cardiovascular complications. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; We examined the…

Arterial hypertensionVascular remodelling0301 basic medicinelcsh:Diseases of the circulatory (Cardiovascular) systemmedicine.medical_specialtyAngiogenesisMatrix metalloproteasesMatrix metalloproteaseHemodynamics030204 cardiovascular system & hematologyPharmacologyMatrix metalloproteinaselcsh:RC870-923Vascular remodelling in the embryoExtracellular matrix03 medical and health scienceschemistry.chemical_compound0302 clinical medicineFibrosisInternal medicinelcsh:DermatologymedicineHumansAntihypertensive AgentsAldosteronebusiness.industryTissue Inhibitor of MetalloproteinasesGeneral Medicinelcsh:RL1-803lcsh:Diseases of the genitourinary system. Urologymedicine.diseaseMatrix Metalloproteinases030104 developmental biologymedicine.anatomical_structurechemistrylcsh:RC666-701Cardiovascular DiseasesNephrologyHypertensionCardiologyArterial hypertension; Matrix metalloproteases; Vascular remodelling; Cardiology and Cardiovascular Medicine; NephrologyCardiology and Cardiovascular MedicinebusinessBlood vesselKidney and Blood Pressure Research
researchProduct

Gelatinases and their tissue inhibitors in a group of subjects with metabolic syndrome.

2013

Aim To evaluate matrix metalloproteases (MMP)-2 and MMP-9 and tissue inhibitor of metalloproteases (TIMP)-1 and TIMP-2 in a group of subjects with metabolic syndrome (MS) subdivided according to the presence or absence of diabetes mellitus. Methods We examined in 90 subjects (51 men and 39 women) with MS, defined following the International Diabetes Federation criteria, and subsequently subdivided into diabetic subjects (22 men and 11 women) and nondiabetic subjects s (29 men and 28 women), the plasma concentrations of MMP-2 and MMP-9 and of TIMP-1 and TIMP-2 using specific enzyme-linked immunosorbent assay kits. Results We found a significant increase in plasma concentrations of MMP-2, MMP…

MaleGelatinasesmedicine.medical_specialtyMatrix metalloproteinase insulin resistanceMatrix metalloproteinaseBiologyMatrix Metalloproteinase InhibitorsGeneral Biochemistry Genetics and Molecular BiologyDiabetes mellitusInternal medicinemedicineMatrix metalloproteasesHumansInternational diabetes federationMetabolic SyndromeMetalloproteinaseTissue Inhibitor of Metalloproteinase-2Tissue Inhibitor of Metalloproteinase-1General MedicineMiddle Agedmedicine.diseaseEndocrinologyMatrix Metalloproteinase 9GelatinasesPlasma concentrationMatrix Metalloproteinase 2FemaleMetabolic syndromeBiomarkersJournal of investigative medicine : the official publication of the American Federation for Clinical Research
researchProduct

Lipid Peroxidation, Protein Oxidation, Gelatinases, and Their Inhibitors in a Group of Adults with Obesity

2019

AbstractThe association between obesity and cardiovascular diseases has a multifactorial pathogenesis, including the synthesis of inflammatory molecules, the increase in oxidative stress and the dysregulation of the matrix metalloprotease (MMP) concentration and activity. In a group of adults with obesity, divided in 2 subgroups according to the body mass index (BMI), we examined lipid peroxidation, expressed as thiobarbituric acid-reactive substances (TBARS), protein oxidation, expressed as protein carbonyl groups (PCs), plasma gelatinases (MMP-2 and MMP-9), and their tissue inhibitors (TIMP-1 and TIMP-2). In the whole group, as well as in the 2 subgroups (with BMI 30–35 or BMI&gt;35) of o…

AdultMalemedicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinology Diabetes and MetabolismClinical Biochemistry030209 endocrinology & metabolism030204 cardiovascular system & hematologyMatrix metalloproteinasemedicine.disease_causeProtein oxidationBiochemistryPathogenesisLipid peroxidation03 medical and health scienceschemistry.chemical_compound0302 clinical medicineEndocrinologyInternal medicineTBARSHumansMedicineObesityTissue Inhibitor of Metalloproteinase-2Tissue Inhibitor of Metalloproteinase-1business.industryBiochemistry (medical)ProteinsGeneral MedicineMiddle Agedmedicine.diseaseObesityOxidative StressEndocrinologyMatrix Metalloproteinase 9chemistryCase-Control Studiesobesity lipid peroxidation protein oxidation gelatinases TIMPsProteolysisMatrix Metalloproteinase 2FemaleLipid PeroxidationbusinessOxidation-ReductionBody mass indexBiomarkersOxidative stressHormone and Metabolic Research
researchProduct

The function of matrix metalloproteinase-9 (MMP-9) and its tissue inhibitor (TIMP-1) in several clinical conditions: Results and analysis of our surv…

2021

The goal of this research was to evaluate the plasma concentration of MMP-9 and its tissue inhibitor (TIMP-1) in different clinical conditions. It included several groups of subjects: 31 overweight subjects; 91 obese adults divided into two subgroups according to the BMI value (BMI 30–35 Kg/m2 and BMI &gt; 35 Kg/m2); 90 subjects with metabolic syndrome (MS) divided into two subgroups (with and without diabetes mellitus); 100 subjects with preclinical carotid atherosclerosis (PCA) divided according to the number of cardiovascular risk factors and to the insulin resistance degree; 48 subjects with obstructive sleep apnoea syndrome (OSAS) divided according to the apnoea/hypopnea index (AHI); 2…

0301 basic medicineAdultmedicine.medical_specialtyPhysiologymedicine.medical_treatment030204 cardiovascular system & hematologyOverweightAdult CKD Humans metabolic syndrome Matrix Metalloproteinase 9 Metabolic Syndrome MMP-9 Obesity OSAS preclinical carotid atherosclerosis Sleep Apnea Obstructive TIMP-1 Tissue Inhibitor of Metalloproteinase-103 medical and health sciences0302 clinical medicineInsulin resistancePhysiology (medical)Diabetes mellitusInternal medicinemedicineHumansObesityDialysisMetabolic SyndromeSleep Apnea ObstructiveTissue Inhibitor of Metalloproteinase-1business.industryHematologymedicine.diseaseObesity030104 developmental biologyMatrix Metalloproteinase 9medicine.symptomMetabolic syndromeCardiology and Cardiovascular MedicinebusinessHypopneaKidney diseaseClinical hemorheology and microcirculation
researchProduct

Nitric oxide metabolites (nitrite and nitrate) in several clinical condition.

2013

We determined the concentration of nitric oxide metabolites (NO2-+NO3-), expressed as NOx, in several clinical conditions. Regarding this, we have examined 25 subjects with arterial hypertension, 41 subjects with chronic kidney disease in conservative treatment, 106 subjects with metabolic syndrome subdivided according to the presence (n = 43) or not (n = 63) of diabetes mellitus, 48 subjects with obstructive sleep apnea syndrome (OSAS), 14 women with systemic sclerosis complicated with Raynaud's phenomenon, 42 dialyzed subjects and 105 young subjects with acute myocardial infarction (AMI). In subjects with arterial hypertension, chronic kidney disease, metabolic syndrome, systemic sclerosi…

inorganic chemicalsAdultMaledialysimedicine.medical_specialtysistemic sclerosiPhysiologykidney diseasemedicine.medical_treatmentNOxNitric OxideAMIRisk FactorsPhysiology (medical)Internal medicineDiabetes mellitusmedicineDiabetes MellitusHumansMyocardial infarctionRenal Insufficiency ChronicDialysisNitritesMetabolic SyndromeNitratesbusiness.industryOSASApneaHematologyrespiratory systemMiddle Agedmedicine.diseaseObstructive sleep apneaEndocrinologyNOx; hypertension; kidney disease; metabolic syndrome; OSAS; sistemic sclerosis; dialysis; AMICardiovascular DiseasesCase-Control StudiesHypertensionCardiologyFemalemedicine.symptomMetabolic syndromeCardiology and Cardiovascular MedicinebusinessHypopneaKidney diseaseClinical hemorheology and microcirculation
researchProduct

Iperviscosita' sclerocitemica da alterazioni congenite della membrana eritrocitaria

2009

sferocitosi ellissocitosi spectrina
researchProduct

La microangiopatia diabetica

2009

microcircolo glicazione non enzimatica beta2-integrine
researchProduct

Emoreologia ed ipertensione

2013

Settore MED/09 - Medicina Internaemoreologia ipertensione
researchProduct

Metalloproteinasi, stress ossidativo e sindrome metabolica

2012

gelatinasi matrice extracellulare aterosclerosi
researchProduct

PMN membrane fluidity, cytosolic Ca2+ content and beta2-integrin pattern in vascular atherosclerotic disease

2010

polymorphonuclear leukocyte adhesion molecules atherosclerosis
researchProduct

Polymorphonuclear leukocyte rheology, cytosolic Ca2+ content, beta2-integrin expression and oxidative stress in hypertension.

2008

Hypertension Leukocyte rheology beta2-integrin oxidative stress.
researchProduct

Comportamento delle gelatinasi e dei loro inibitori tissutali nella sindrome metabolica

2013

gelatinasi sindrome metabolica
researchProduct

Membrane fluidity and cytosolic Ca2+ concentration of the circulating polymorphonuclear leukocytes in diabetes mellitus

2014

granulocyte fluorescence spectroscopy atherosclerosisSettore MED/09 - Medicina Interna
researchProduct

Metabolic syndrome: from insulin resistance to adipose tissue dysfunction.

2008

Recently the definition, the pathophysiology and even the clinical utility of metabolic syndrome (MS) have been discussed. The risk induced by each component of the metabolic syndrome is higher than the risk induced by MS alone. MS alone is, in fact, a weaker predictor of cardiovascular disease than diabetes. New criteria to define the metabolic syndrome have been proposed, as adipokines, CRP and PAI-1. IGFBP-1 is related to hyperinsulinemia/insulin resistance and to the risk of diabetes and fatal ischemic heart disease development. IGF/IGFBP system could be a link between insulin resistance and cardiovascular disease. RBP-4 can attenuate insulin signalling in skeletal muscle and induce hep…

researchProduct

Studio delle interrelazioni tra stress ossidativo, gelatinasi e loro inibitori in soggetti con sindrome delle apnee ostruttive nel sonno

2015

Sindrome delle apnee ostruttive; stress ossidativo; perossidazione lipidica; gelatinasistress ossidativogelatinasiperossidazione lipidicaSindrome delle apnee ostruttive
researchProduct

Deformabilità eritrocitaria e metaboliti dell'ossido nitrico in un gruppo di soggetti con sindrome delle apnee ostruttive nel sonno

2013

Settore MED/09 - Medicina Internaeritrociti NOx OSAS
researchProduct

Alterazioni funzionali leucocitarie nella malattia ipertensiva

2009

ipertensione arteriosa beta2-integrine calcio leucocitario
researchProduct

Aspetti emoreologici nella iperviscosità policitemica e sierica

2015

I fattori strutturali in grado di modificare la viscosità ematica sono la massa cellulare, le frazioni proteiche plasmatiche e la deformabilità del globulo rosso. In base alla presenza di uno di questi fattori si distinguono le diverse condizioni primarie di iperviscosità. Mentre l'iperviscosità policitemica è possibile riscontrarla in molti quadri clinici caratterizzati dall'aumento della massa cellulare (policitemia vera, eritrocitosi, leucocitosi iperleucocitiche, trombocitemia), l'iperviscosità sierica è probabile evidenziarla in quadri clinici diversi quali mieloma, malattia di Waldenstrom, crioglobulinemia, disfibrinogenemie, malattie del connettivo, e l'iperviscosità sclerocitemica è…

Sindrome da iperviscosità; policitemia vera; mieloma multiplo; deformabilità eritrocitaria; lipidi della membrana eritrocitariadeformabilità eritrocitariaSindrome da iperviscositàpolicitemia veramieloma multiplolipidi della membrana eritrocitaria
researchProduct

Ulcere venose: rilievi riguardanti sia aspetti reologici e funzionali dei polimorfonucleati che le concentrazioni plasmatiche delle gelatinasi e dei …

2014

Settore MED/09 - Medicina Internametalloprotease chronic venous insufficiency granulocyte membrane
researchProduct

Alterazioni emoreologiche nella sindrome metabolica

2015

La sindrome metabolica (SM) si accompagna ad un elevato rischio cardiovascolare. Oltre ai tradizionali fattori di rischio, dei quali la SM rappresenta un’aggregazione, sono identificabili fattori non tradizionali quali l’assetto emoreologico. È noto da tempo che un disordine emoreologico si accompagna alla SM, ed è ipotizzabile una sua influenza sui meccanismi che instaurano e mantengono l’insulino-resistenza. In un gruppo di pazienti con SM abbiamo osservato un incremento della viscosità ematica e plasmatica e una riduzione della filtrabilità ematica. Il rapporto vita-fianchi, indice di obesità addominale, era direttamente correlato con la viscosità ematica e con l’ematocrito, mentre la vi…

stress ossidativoemoreologiaSindrome metabolicaSindrome metabolica; emoreologia; gelatinasi; stress ossidativogelatinasi
researchProduct

Leucociti polimorfonucleati e diabete mellito

2011

Fluidità della membrana leucocitaria integrine leucocitarie attivazione leucocitaria
researchProduct

Deformabilità eritrocitaria nella policitemia vera

2011

Diffrattometria rischio trombotico
researchProduct

Polymorphonuclear leukocytes and diabetes mellitus.

2008

Diabetic subjects have a higher infective risk than healthy people, with more frequent and severe infections. This predisposition to infections is determined by hyperglycemia, microangiopathy and altered immune system. In particular, there is a polymorphonuclear leukocytes disfunction including chemotaxis, phagocytosis, bacterial killing and cellular activation by infective stimulus. These alterations are due to abnormal properties of polymorphonuclear leukocytes (PMN) in diabetic patients. Several parameters like phagocytosis of bacterial cells, chemiluminescence during oxidative burst and cell membrane deformability are related to glycaemia and glycated hemoglobin. Recent acquisitions sho…

researchProduct

Molecole di adesione e malattia diabetica

2010

aterosclerosi diabete mellito flogosi leucociti molecole di adesione solubili stress ossidativo
researchProduct

Studio dei parametri dello stress ossidativo e della reologia eritrocitaria in soggetti affetti da sindrome delle apnee ostruttive nel sonno (OSAS)

stress ossidativoSettore MED/09 - Medicina InternaOSASreologia eritrocitaria
researchProduct

Lipid peroxidation and protein oxidation are related to the severity of OSAS

2014

oxidative stresleep apnoeaoxygen saturation
researchProduct

Red blood cell deformability in multiple myeloma

2018

The aim of this study was the evaluation of the erythrocyte deformability in multiple myeloma (MM). We enrolled 29MM patients and we evaluated, on fasting venous blood, the erythrocyte deformability, expressed as elongation index, and examined using the diffractometric method. By comparing normal controls and MM patients, a significant decrease in erythrocyte deformability, especially at low shear stresses, was found. In this research paper we evaluated all the hypothesis for a possible explanation of the behaviour of red blood cell deformability in MM, even considering how the alteration of erythrocyte deformability worsens the microcirculatory flow in these patients in association with th…

erythrocyte deformabilityMaleMultiple myelomaPhysiologyPhysiology (medical)MicrocirculationFemaleHematologyCardiology and Cardiovascular MedicineAgedHuman
researchProduct

Deformabilità eritrocitaria, metaboliti dell'ossido nitrico e stress ossidativo in un gruppo di soggetti con sindrome delle apnee ostruttive nel sonno

2015

La sindrome delle apnee ostruttive nel sonno ((OSAS) si associa a disfunzione endoteliale ed aterosclerosi ed è gravata da un'elevata morbilità e mortalità cardiovascolare.

deformabilità eritrocitariaperossidazione lipidicaSindrome delle apnee ostruttive; deformabilità eritrocitaria; ossido nitrico; perossidazione lipidicaossido nitricoSindrome delle apnee ostruttive
researchProduct

Eventi vascolari correlati ad alcune condizioni di iperviscosità sclerocitemica

2014

Settore MED/09 - Medicina Internaerythrocyte membrane hereditary spherocytosis hereditary elliptocytosis acanthocytosis
researchProduct